Acute Stroke Therapy With Tissue Plasminogen Activator (tPA) Since It Was Approved by the U.S. Food and Drug Administration (FDA)ZIVIN, Justin A.Annals of neurology. 2009, Vol 66, Num 1, pp 6-10, issn 0364-5134, 5 p.Article

Clinical trials of neuroprotective therapiesZIVIN, Justin A.Stroke (1970). 2007, Vol 38, Num 2, pp 791-793, issn 0039-2499, 3 p., SUPConference Paper

Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours conZIVIN, Justin A.Stroke (1970). 2005, Vol 36, Num 5, pp 1099-1100, issn 0039-2499, 2 p.Article

SLOW-MAGZIVIN, Justin A.Stroke (1970). 2004, Vol 35, Num 7, pp 1776-1777, issn 0039-2499, 2 p.Article

Empirical Characteristics of Litigation Involving Tissue Plasminogen Activator and Ischemic StrokeLIANG, Bryan A; ZIVIN, Justin A.Annals of emergency medicine. 2008, Vol 52, Num 2, pp 160-164, issn 0196-0644, 5 p.Article

Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: Synergism with low-dose tissue plasminogen activatorLAPCHAK, Paul A; ZIVIN, Justin A.Stroke (1970). 2003, Vol 34, Num 8, pp 2013-2018, issn 0039-2499, 6 p.Article

The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits : A combination therapy study with tissue plasminogen activatorLAPCHAK, Paul A; ZIVIN, Justin A.Experimental neurology (Print). 2009, Vol 215, Num 1, pp 95-100, issn 0014-4886, 6 p.Article

Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbitsLAPCHAK, Paul A; JIANDONG WEI; ZIVIN, Justin A et al.Stroke (1970). 2004, Vol 35, Num 8, pp 1985-1988, issn 0039-2499, 4 p.Article

Inter-relationships between spinal cord blood flow, neuronal death and neurological function in rabbit spinal cord ischemiaWEIR, Christopher J; ZIVIN, Justin A; LYDEN, Patrick D et al.Brain research. 2002, Vol 946, Num 1, pp 43-51, issn 0006-8993Article

Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidenceLAPCHAK, Paul A; DONGHUAN SONG; JIANDONG WEI et al.Experimental neurology (Print). 2004, Vol 188, Num 2, pp 286-291, issn 0014-4886, 6 p.Article

Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: Combination studies with the thrombolytic tissue plasminogen activatorLAPCHAK, Paul A; CHAPMAN, Deborah F; ZIVIN, Justin A et al.Stroke (1970). 2001, Vol 32, Num 1, pp 147-153, issn 0039-2499Conference Paper

Continuous intrathecal fluid infusions elevate nerve growth factor levels and prevent functional deficits after spinal cord ischemiaBOWES, Mark; TUSZYNSKI, Mark H; CONNER, Jim et al.Brain research. 2000, Vol 883, Num 2, pp 178-183, issn 0006-8993Article

Reasons why few patients with acute stroke receive tissue plasminogen activatorBAMBAUER, Kara Z; JOHNSTON, S. Claibome; BAMBAUER, Derek E et al.Archives of neurology (Chicago). 2006, Vol 63, Num 5, pp 661-664, issn 0003-9942, 4 p.Article

Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbitsLAPCHAK, Paul A; KIRKEBY, Agnete; ZIVIN, Justin A et al.Brain research. 2008, Vol 1238, pp 208-214, issn 0006-8993, 7 p.Article

Safety Profile of Transcranial Near-Infrared Laser Therapy Administered in Combination With Thrombolytic Therapy to Embolized RabbitsLAPCHAK, Paul A; HAN, Moon-Ku; SALGADO, Karmen F et al.Stroke (1970). 2008, Vol 39, Num 11, pp 3073-3078, issn 0039-2499, 6 p.Article

Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: Combination studies with the thrombolytic tissue plasminogen activatorLAPCHAK, Paul A; ARAUJO, Dalia M; DONGHUAN SONG et al.Stroke (1970). 2002, Vol 33, Num 5, pp 1411-1415, issn 0039-2499Article

Effects of intrathecal administration of a cell permeant caspase inhibitor, boc-D-fluoromethylketone (BDFMK), on behavioral deficits following spinal cord ischemia: a dose-response analysisLAPCHAK, Paul A; ARAUJO, Dalia M; WEIR, Christopher J et al.Brain research. 2003, Vol 959, Num 2, pp 183-190, issn 0006-8993, 8 p.Article

The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic strokeLAPCHAK, Paul A; ARAUJO, Dalia M; SONG, Donghuan et al.Stroke (1970). 2002, Vol 33, Num 1, pp 147-152, issn 0039-2499Article

Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemiaLAPCHAK, Paul A; ARAUJO, Dalia M; DONHUANG SONG et al.Stroke (1970). 2001, Vol 32, Num 5, pp 1220-1225, issn 0039-2499Article

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. CommentaryLAPCHAK, Paul A; CHAPMAN, Deborah F; ZIVIN, Justin A et al.Stroke (1970). 2000, Vol 31, Num 12, pp 3034-3040, issn 0039-2499Article

Risk of Stroke and Cardiovascular Events After Ischemic Stroke or Transient Ischemic Attack in Patients With Type 2 Diabetes or Metabolic Syndrome: Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) TrialCALLAHAN, Alfred; AMARENCO, Pierre; HENNERICI, Michael et al.Archives of neurology (Chicago). 2011, Vol 68, Num 10, pp 1245-1251, issn 0003-9942, 7 p.Article

Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. CommentaryKAPLAN, Stuart S; PARK, T. S; GONZALES, Ernesto R et al.Stroke (1970). 2000, Vol 31, Num 9, pp 2218-2223, issn 0039-2499Article

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialAMARENCO, Pierre; GOLDSTEIN, Larry B; CALLAHAN, Alfred et al.Atherosclerosis. 2009, Vol 204, Num 2, pp 515-520, issn 0021-9150, 6 p.Article

Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic StrokeZIVIN, Justin A; ALBERS, Gregory W; KASNER, Scott et al.Stroke (1970). 2009, Vol 40, Num 4, pp 1359-1364, issn 0039-2499, 6 p.Article

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic Stroke in the SAINT I trialLEES, Kennedy R; DAVALOS, Antonio; EMERIBE, Ugochi et al.Stroke (1970). 2006, Vol 37, Num 12, pp 2970-2978, issn 0039-2499, 9 p.Article